Clesrovimab (MK-1654) in Infants and Children at Increased Risk for Severe Respiratory Syncytial Virus (RSV) Disease (MK-1654-007)

NCT ID: NCT04938830

Last Updated: 2025-10-29

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE3

Total Enrollment

1003 participants

Study Classification

INTERVENTIONAL

Study Start Date

2021-11-30

Study Completion Date

2025-08-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study aims to evaluate the safety and tolerability of clesrovimab compared to palivizumab as assessed by the proportion of participants experiencing adverse events (AEs).

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

RSV Infection

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

PREVENTION

Blinding Strategy

TRIPLE

Participants Caregivers Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Clesrovimab

Participants will receive intramuscular (IM) injections of clesrovimab and placebo

Group Type EXPERIMENTAL

Clesrovimab

Intervention Type BIOLOGICAL

IM injection

Placebo

Intervention Type BIOLOGICAL

IM injection

Palivizumab

Participants will receive IM injections.

Group Type ACTIVE_COMPARATOR

Palivizumab

Intervention Type BIOLOGICAL

IM injection

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Clesrovimab

IM injection

Intervention Type BIOLOGICAL

Palivizumab

IM injection

Intervention Type BIOLOGICAL

Placebo

IM injection

Intervention Type BIOLOGICAL

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

MK-1654

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Participants at increased risk for severe RSV infection recommended to receive palivizumab in accordance with national or local guidelines or professional society recommendations.
* Is available to complete the follow-up period.

Exclusion Criteria

* Requires mechanical ventilation at time of enrollment.
* Has a life expectancy \<6 months.
* Has known hepatic or renal dysfunction, or chronic seizure disorder.
* Is hospitalized at the time of randomization unless discharge is expected within 7 days after randomization.
* Has severe immunodeficiency or is severely immunocompromised.
* Has known hypersensitivity to any component of clesrovimab or palivizumab.
Maximum Eligible Age

1 Year

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Merck Sharp & Dohme LLC

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Medical Director

Role: STUDY_DIRECTOR

Merck Sharp & Dohme LLC

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Miller Children's & Women's Hospital Long Beach ( Site 0001)

Long Beach, California, United States

Site Status

Children's Hospital of Orange County ( Site 0047)

Orange, California, United States

Site Status

Children's Hospital Colorado ( Site 0011)

Aurora, Colorado, United States

Site Status

Children's National Medical Center ( Site 0020)

Washington D.C., District of Columbia, United States

Site Status

Orlando Health - Arnold Palmer Hospital-Orlando Health-Arnold Palmer Hospital Pulmonary and Sleep M ( Site 0022)

Orlando, Florida, United States

Site Status

Nemours Children's Health, Lake Nona Medical City ( Site 0032)

Orlando, Florida, United States

Site Status

University of South Florida-Department of Pediatrics ( Site 0045)

Tampa, Florida, United States

Site Status

Morehouse School Of Medicine ( Site 0049)

Atlanta, Georgia, United States

Site Status

Clinical Research Prime ( Site 0046)

Idaho Falls, Idaho, United States

Site Status

University of Kentucky HealthCare - Turfland ( Site 0044)

Lexington, Kentucky, United States

Site Status

Our Lady of the Lake Children's Hospital ( Site 0031)

Baton Rouge, Louisiana, United States

Site Status

Tulane University School of Medicine ( Site 0010)

New Orleans, Louisiana, United States

Site Status

M Health Fairview University of Minnesota Masonic Children's Hospital, West Bank-Peds Research ( Site 0037)

Minneapolis, Minnesota, United States

Site Status

Rutgers University-Pediatric Clinical Research Center ( Site 0007)

New Brunswick, New Jersey, United States

Site Status

NYU Langone Hospital - Long Island-Pediatrics ( Site 0028)

Mineola, New York, United States

Site Status

University of Rochester Medical Center ( Site 0017)

Rochester, New York, United States

Site Status

The University of North Carolina at Chapel Hill ( Site 0035)

Chapel Hill, North Carolina, United States

Site Status

Duke University ( Site 0021)

Durham, North Carolina, United States

Site Status

Dayton Children's Hospital ( Site 0053)

Dayton, Ohio, United States

Site Status

Tribe Clinical Research, LLC ( Site 0002)

Greenville, South Carolina, United States

Site Status

Driscoll Children's Hospital ( Site 0025)

Corpus Christi, Texas, United States

Site Status

DHR Health Institute for Research and Development ( Site 0029)

Edinburg, Texas, United States

Site Status

Christus Children's-Clinical Research Center ( Site 0038)

San Antonio, Texas, United States

Site Status

University Hospital-Pediatrics ( Site 0019)

San Antonio, Texas, United States

Site Status

Road Runner Research, Ltd ( Site 0052)

San Antonio, Texas, United States

Site Status

Intermountain - Primary Children's Hospital ( Site 0026)

Salt Lake City, Utah, United States

Site Status

Multicare Rockwood Main Clinic-Rockwood Pediatrics ( Site 0004)

Spokane, Washington, United States

Site Status

Providence Sacred Heart Medical Center & Children's Hospital ( Site 0030)

Spokane, Washington, United States

Site Status

MultiCare Health System-Baker Center ( Site 0036)

Tacoma, Washington, United States

Site Status

Mater Misericordiae Limited-Neonatalogy ( Site 0102)

Brisbane, Queensland, Australia

Site Status

Telethon Kids Institute-Vaccine Trials Group ( Site 0101)

Nedlands, Western Australia, Australia

Site Status

Alberta Children's Hospital-Department of Pediatrics ( Site 0180)

Calgary, Alberta, Canada

Site Status

Canadian Center for Vaccinology ( Site 0179)

Halifax, Nova Scotia, Canada

Site Status

CHU Sainte-Justine ( Site 0178)

Montreal, Quebec, Canada

Site Status

Clínica Alemana de Santiago-Neonatology department ( Site 0207)

Santiago, Region M. de Santiago, Chile

Site Status

Hospital Roberto del Río-Infectología Pediátrica ( Site 0205)

Santiago, Region M. de Santiago, Chile

Site Status

Hospital Padre Hurtado-NEONATOLOGY/PEDIATRICS ( Site 0201)

Santiago, Region M. de Santiago, Chile

Site Status

Fundación Hospitalaria San Vicente de Paúl ( Site 0233)

Medellín, Antioquia, Colombia

Site Status

Clínica Universitaria Bolivariana ( Site 0227)

Medellín, Antioquia, Colombia

Site Status

Ciensalud Ips S A S ( Site 0235)

Barranquilla, Atlántico, Colombia

Site Status

Sociedad de Cirugía de Bogotá - Hospital de San Jose ( Site 0230)

Bogotá, Bogota D.C., Colombia

Site Status

Clínica Imbanaco S.A.S ( Site 0229)

Cali, Valle del Cauca Department, Colombia

Site Status

Fakultni nemocnice Ostrava-Oddeleni neonatologie ( Site 0252)

Ostrava, Moravskoslezský kraj, Czechia

Site Status

Institute for the Care of Mother and Child ( Site 0251)

Prague, Praha 4, Czechia

Site Status

FVR, Kokkolan rokotetutkimusklinikka ( Site 0304)

Kokkola, Keski-Pohjanmaa, Finland

Site Status

FVR, Oulun rokotetutkimusklinikka ( Site 0303)

Oulu, North Ostrobothnia, Finland

Site Status

FVR, Tampereen rokotetutkimusklinikka ( Site 0301)

Tampere, Pirkanmaa, Finland

Site Status

FVR, Seinäjoen rokotetutkimusklinikka ( Site 0305)

Seinäjoki, South Ostrobothnia, Finland

Site Status

FVR, Turun rokotetutkimusklinikka ( Site 0302)

Turku, Southwest Finland, Finland

Site Status

MeVac - Meilahti Vaccine Research Center ( Site 0306)

Helsinki, Uusimaa, Finland

Site Status

Bordeaux University Hospital - Pellegrin-Pediatrics ( Site 0332)

Bordeaux, Aquitaine, France

Site Status

Centre Hospitalier Universitaire de Caen - Hôpital Côte de N-Centre de Recherche Clinique Pédiatriq ( Site 0330)

Caen, Calvados, France

Site Status

Centre Hospitalier de Versailles André Mignot-NEONATOLOGY ( Site 0331)

Le Chesnay, Yvelines, France

Site Status

Universitaetsklinikum Freiburg ( Site 0365)

Freiburg im Breisgau, Baden-Wurttemberg, Germany

Site Status

Universitaetsklinikum Heidelberg-Zentrum für Kinder-und Jugendmedizin ( Site 0366)

Heidelberg, Baden-Wurttemberg, Germany

Site Status

Dr. von Haunersches Kinderspital ( Site 0358)

Munich, Bavaria, Germany

Site Status

München Klinik Harlaching ( Site 0351)

Munich, Bavaria, Germany

Site Status

Medizinische Hochschule Hannover ( Site 0364)

Hanover, Lower Saxony, Germany

Site Status

Kinder und Jugendaerztliche Gemeinschaftspraxis Bedikian & Bouikidis ( Site 0359)

Oberhausen, North Rhine-Westphalia, Germany

Site Status

Universitaetsklinikum Carl Gustav Carus Dresden-Klinik und Poliklinik für Kinder- und Jugendmedizin ( Site 0363)

Dresden, Saxony, Germany

Site Status

Universitätsklinikum Leipzig-Neonatology ( Site 0354)

Leipzig, Saxony, Germany

Site Status

Universitätsklinikum Schleswig-Holstein-Pediatrics ( Site 0361)

Lübeck, Schleswig-Holstein, Germany

Site Status

Aghia Sophia Children's Hospital-First Department of Pediatrics, National and Kapodistrian Universi ( Site 0852)

Athens, Attica, Greece

Site Status

Children's Hospital Aglaia Kyriakou-2nd Department of Pediatrics NKUA ( Site 0854)

Athens, Attica, Greece

Site Status

ATTIKON GENERAL UNIVERSITY HOSPITAL-3rd Department of Pediatrics ( Site 0855)

Chaïdári, Attica, Greece

Site Status

Hippokration University Hopsital-3rd Pediatric Department ( Site 0851)

Thessaloniki, Central Macedonia, Greece

Site Status

Prince of Wales Hospital ( Site 0926)

Shatin, , Hong Kong

Site Status

Tuen Mun Hospital ( Site 0927)

Tuenmen, , Hong Kong

Site Status

Borsod-Abaúj-Zemplén Megyei Központi Kórház és Egyetemi Oktatókórház-Újszülött Intenzív Osztály ( Site 0388)

Miskolc, Borsod-Abauj Zemplen county, Hungary

Site Status

Bajai Szent Rókus Kórház ( Site 0386)

Baja, Bács-Kiskun county, Hungary

Site Status

Bacs-Kiskun Megyei Korhaz-Pediatrics ( Site 0380)

Kecskemét, Bács-Kiskun county, Hungary

Site Status

Szabolcs-Szatmar-Bereg Varmegyei Korhazak es Egyetemi Oktatokorhaz - Gyermekosztaly ( Site 0376)

Nyíregyháza, Szabolcs-Szatmár-Bereg, Hungary

Site Status

Péterfy Kórház-Rendelőintézet és Manninger Jenő Országos Traumatológiai Intézet-PIC ( Site 0384)

Budapest, , Hungary

Site Status

Semmelweis University-Szülészeti és Nőgyógyászati Klinika PIC ( Site 0381)

Budapest, , Hungary

Site Status

Gottsegen György Országos Kardiovaszkuláris Intézet ( Site 0383)

Budapest, , Hungary

Site Status

Debreceni Egyetem Klinikai Kozpont ( Site 0378)

Debrecen, , Hungary

Site Status

Ospedale Pediatrico Bambino Gesù IRCCS-UOC Broncopneumologia ( Site 0427)

Rome, Lazio, Italy

Site Status

Fondazione Policlinico Universitario Agostino Gemelli ( Site 0426)

Rome, Lazio, Italy

Site Status

Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico ( Site 0432)

Milan, Lombardy, Italy

Site Status

ASST Fatebenefratelli Sacco ( Site 0434)

Milan, Lombardy, Italy

Site Status

Azienda Ospedaliera di Padova-Department of Women and Child Health ( Site 0428)

Padua, Veneto, Italy

Site Status

Azienda Ospedaliero Universitaria di Parma-UO Clinica Pediatrica ( Site 0433)

Parma, , Italy

Site Status

Fukuoka Children's Hospital ( Site 0452)

Fukuoka, Fukuoka, Japan

Site Status

Iizuka Hospital ( Site 0457)

Iizuka, Fukuoka, Japan

Site Status

Japan Community Healthcare Organization Kyushu Hospital ( Site 0454)

Kitakyushu-shi, Fukuoka, Japan

Site Status

Maebashi Red Cross Hospital ( Site 0451)

Maebashi, Gunma, Japan

Site Status

Ibaraki Children's Hospital ( Site 0458)

Mito, Ibaraki, Japan

Site Status

Nihon University Itabashi Hospital ( Site 0453)

Itabashiku, Tokyo, Japan

Site Status

Shizuoka Saiseikai General Hospital ( Site 0456)

Shizuoka, , Japan

Site Status

National Center for Child Health and Development ( Site 0455)

Tokyo, , Japan

Site Status

Hospital Raja Perempuan Zainab II-Department of Pediatric ( Site 0477)

Kota Bharu, Kelantan, Malaysia

Site Status

University Malaya Medical Centre-Department of Paediatrics ( Site 0480)

Lembah Pantai, Kuala Lumpur, Malaysia

Site Status

Hospital Pulau Pinang ( Site 0482)

George Town, Pulau Pinang, Malaysia

Site Status

Sabah Women and Children Hospital ( Site 0478)

Kota Kinabalu, Sabah, Malaysia

Site Status

Hospital Sibu ( Site 0476)

Sibu, Sarawak, Malaysia

Site Status

Hospital Tunku Azizah-Paediatric ( Site 0481)

Kuala Lumpur, , Malaysia

Site Status

Morales Vargas Centro de Investigacion ( Site 0509)

León, Guanajuato, Mexico

Site Status

Centro de Investigación Médico Biológica y Terapia Avanzada ( Site 0502)

Guadalajara, Jalisco, Mexico

Site Status

Instituto Nacional de Pediatria ( Site 0506)

Mexico City, Mexico City, Mexico

Site Status

Instituto de Investigaciones Aplicadas a la Neurociencia A.C. ( Site 0508)

Durango, , Mexico

Site Status

Oaxaca Site Management Organization ( Site 0504)

Oaxaca City, , Mexico

Site Status

ONCOLOGICO POTOSINO, S.C. ( Site 0505)

San Luis Potosí City, , Mexico

Site Status

Capital and Coast District Health Board-Clinical Trials Unit ( Site 0527)

Newtown, Wellington Region, New Zealand

Site Status

Middlemore Clinical Trials ( Site 0526)

Auckland, , New Zealand

Site Status

Oslo Universitetssykehus Ullevål ( Site 0551)

Oslo, , Norway

Site Status

Instituto Nacional Cardiovascular INCOR Carlos Peschiera Carrillo - EsSalud ( Site 0577)

Jesús María, Lima, Peru

Site Status

HOSPITAL DOCENTE MADRE-NIÑO SAN BARTOLOME-NEUMOLOGIA PEDIATRICA ( Site 0576)

Lima, , Peru

Site Status

UPR Medical Sciences Campus-Pediatrics ( Site 0626)

San Juan, , Puerto Rico

Site Status

KK Women's and Children's Hospital-Department of Neonatology ( Site 0877)

Singapore, South West, Singapore

Site Status

Reimed ( Site 0706)

Boksburg, Gauteng, South Africa

Site Status

Chris Hani Baragwanath Academic Hospital ( Site 0701)

Soweto, Gauteng, South Africa

Site Status

King Edward VIII Hospital ( Site 0704)

Durban, KwaZulu-Natal, South Africa

Site Status

Family Clinical Research Unit (Fam-Cru)-Pediatric ( Site 0703)

Cape Town, Western Cape, South Africa

Site Status

Panorama Medical Centre ( Site 0702)

Cape Town, Western Cape, South Africa

Site Status

MRC Unit on Child And Adolescent Health-Department of Paediatrics and child Health ( Site 0710)

Cape Town, Western Cape, South Africa

Site Status

2 Military Hospital ( Site 0708)

Cape Town, Western Cape, South Africa

Site Status

Hospital Germans Trias i Pujol ( Site 0738)

Badalona, Barcelona, Spain

Site Status

Hospital Sant Joan de Déu ( Site 0730)

Esplugues de Llobregat, Barcelona, Spain

Site Status

Hospital Universitary General de Catalunya-Pediatrics ( Site 0737)

Sant Cugat del Vallès, Barcelona, Spain

Site Status

CHUS - Hospital Clinico Universitario-Servicio de Pediatría ( Site 0731)

Santiago de Compostela, La Coruna, Spain

Site Status

Hospital Universitario HM Monteprincipe-pediatric ( Site 0743)

Boadilla del Monte, Madrid, Spain

Site Status

HOSPITAL UNIVERSITARIO QUIRONSALUD MADRID ( Site 0739)

Pozuelo de Alarcón, Madrid, Spain

Site Status

Hospital Universitario 12 de Octubre-Unidad Pediátrica de Investigación y Ensayos Clínicos ( Site 0728)

Madrid, Madrid, Comunidad de, Spain

Site Status

Hospital Universitario Central de Asturias ( Site 0740)

Oviedo, Principality of Asturias, Spain

Site Status

Hospital Universitario La Paz ( Site 0726)

Madrid, , Spain

Site Status

Grupo Pediatrico Uncibay ( Site 0734)

Málaga, , Spain

Site Status

Taichung Veterans General Hospital ( Site 0754)

Taichung, , Taiwan

Site Status

National Taiwan University Hospital ( Site 0751)

Taipei, , Taiwan

Site Status

Mackay Memorial Hospital-Pediatrics ( Site 0753)

Taipei, , Taiwan

Site Status

Chang Gung Medical Foundation-Linkou Branch ( Site 0752)

Taoyuan District, , Taiwan

Site Status

Chulalongkorn University-Pediatrics ( Site 0777)

Bangkok, Bangkok, Thailand

Site Status

Faculty of Medicine Siriraj Hospital-Pediatric Infectious Diseases ( Site 0778)

Bangkok, Bangkok, Thailand

Site Status

Songklanagarind hospital-Department of Pediatrics ( Site 0776)

Hat Yai, Changwat Songkhla, Thailand

Site Status

cukurova universty ( Site 0805)

Sarçam, Adana, Turkey (Türkiye)

Site Status

Ankara University Hospital Cebeci ( Site 0801)

Ankara, , Turkey (Türkiye)

Site Status

Gazi Universitesi ( Site 0806)

Ankara, , Turkey (Türkiye)

Site Status

Ankara Bilkent Şehir Hastanesi. ( Site 0807)

Ankara, , Turkey (Türkiye)

Site Status

Erciyes University Medical Faculty-pediatric infection ( Site 0804)

Kayseri, , Turkey (Türkiye)

Site Status

Whipps Cross University Hospital ( Site 0846)

London, England, United Kingdom

Site Status

St. George's Hospital ( Site 0845)

London, England, United Kingdom

Site Status

Queen Elizabeth University Hospital ( Site 0842)

Glasgow, Glasgow City, United Kingdom

Site Status

Evelina London Children's Hospital ( Site 0829)

London, Great Britain, United Kingdom

Site Status

Southampton General Hospital ( Site 0826)

Southampton, Hampshire, United Kingdom

Site Status

Barts Health NHS Trust-Children's Clinical Research Facility ( Site 0844)

London, London, City of, United Kingdom

Site Status

The John Radcliffe Hospital-Paediatrics Infectious Diseases ( Site 0827)

Oxford, Oxfordshire, United Kingdom

Site Status

Alder Hey Children's Hospital-Paediatric Respiratory Medicine ( Site 0843)

Liverpool, , United Kingdom

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States Australia Canada Chile Colombia Czechia Finland France Germany Greece Hong Kong Hungary Italy Japan Malaysia Mexico New Zealand Norway Peru Puerto Rico Singapore South Africa Spain Taiwan Thailand Turkey (Türkiye) United Kingdom

References

Explore related publications, articles, or registry entries linked to this study.

Zar HJ, Bont LJ, Manzoni P, Munoz FM, Ramilo O, Chen PY, Novoa JM, Ordonez GA, Tsolia M, Tapiero B, Acuna-Avila MI, Castellanos JM, Meyer M, Morioka I, Chen Z, Railkar RA, Zang X, Maas BM, Likos A, Lee AW, Castagnini LA, Sinha A; SMART (MK-1654-007) Study Group. Clesrovimab in Infants and Children at Increased Risk for Severe RSV Disease. N Engl J Med. 2025 Oct 2;393(13):1343-1345. doi: 10.1056/NEJMc2506107. Epub 2025 Sep 17. No abstract available.

Reference Type RESULT
PMID: 40961423 (View on PubMed)

Sinha A, Railkar RA, Castagnini L, Guerra A, Likos A, Lutkiewicz J, Maas BM, Zang X, Roadcap BA, Choi Y, Nahhas GJ, Arriola CS, Bont L, Manzoni P, Ramilo O, Munoz FM, Finelli L, Lee AW. Evaluation of a monoclonal antibody against respiratory syncytial virus, clesrovimab, in infants and children: Comprehensive rationale and study design for the late-stage clinical trials. Contemp Clin Trials. 2025 Oct;157:107995. doi: 10.1016/j.cct.2025.107995. Epub 2025 Jun 30.

Reference Type DERIVED
PMID: 40602662 (View on PubMed)

Related Links

Access external resources that provide additional context or updates about the study.

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

MK-1654-007

Identifier Type: OTHER

Identifier Source: secondary_id

jRCT2031210664

Identifier Type: REGISTRY

Identifier Source: secondary_id

2022-500752-39-00

Identifier Type: REGISTRY

Identifier Source: secondary_id

U1111-1278-0093

Identifier Type: REGISTRY

Identifier Source: secondary_id

2020-005996-11

Identifier Type: EUDRACT_NUMBER

Identifier Source: secondary_id

1654-007

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.